Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

The world’s top ten orphan drugs in oncology in 2018

The top ten orphan drugs in oncology accounted for approximately $54.1bn in net sales in 2018, with just three of Roche’s drugs Herceptin, Avastin and Rituxan collectively accounting for approximately 35%. Pharmaceutical-technology.com lists the world’s top ten orphan drugs in oncology based on sales.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close
Globaldata

Identify the key trends in the immuno-oncology market over the next two years

Close

Go Top